Back to Search

KIMBERLY FERRANTE, MD

MD

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

NPI: 1942468830Individual

Specialties, Licenses & Credentials

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary

Obstetrics & Gynecology — Urogynecology and Reconstructive Pelvic Surgery

Code: 207VF0040X

A120761(CA)

Research & Publications (13)

Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS).
PMID 16963407·Amyotroph Lateral Scler·2006
4-observational
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.
PMID 16344537·Neurology·2005
3-trial
Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives.
PMID 15699374·Neurology·2005
4-observational
A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors.
PMID 15592721·Cancer Chemother Pharmacol·2005
3-trial
A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors.
PMID 15534083·Clin Cancer Res·2004
3-trial
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice.
PMID 12787055·J Neurochem·2003
7-preclinical
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.
PMID 11880489·J Neurosci·2002
7-preclinical
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease.
PMID 11456300·Ann Neurol·2001
7-preclinical
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease.
PMID 11447996·Neurobiol Dis·2001
7-preclinical
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.
PMID 11432895·J Clin Oncol·2001
3-trial
Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel.
PMID 11331328·J Clin Oncol·2001
3-trial
Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation.
PMID 11299300·J Neurochem·2001
7-preclinical
Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice.
PMID 11259130·Exp Neurol·2001
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
150 E 32ND ST FL 2, NYU UROLOGY ASSOCIATES
NEW YORK, NY 10016

Location

Practice Location

150 E 32ND ST FL 2, NEW YORK, NY
(212) 545-5400

Quick Facts

NPI
1942468830
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
13

Are you this provider?

Claim Your Profile